• P&L ownership of $110M APAC Baby Gear Business as well as ownership of cross functional operating rhythm and strategy for $1.3B global Baby division.• Modified decision rights for the regional organizations resulting in empowered regions with the ability to make decisions on ~75% of items that used to go to the global organization. • Created and am driving a prioritized list of global divisional priorities across sales, marketing, supply chain, and R&D to achieve financial targets for current year and beyond.

• PMO lead for driving Newell’s Cost Savings Programs. Program consists of post-acquisition Procurement Savings, Indirect Spend Optimization, Product Redesign, Global Business Services Launch, Supply Chain Redesign, and Commercial Org Redesign. Program on track to deliver over $1B of synergies. • Developed, with the CIO, a multi-year ERP roadmap with the supporting business case. Roadmap approved by CFO and CTO. • Responsible for directly leading the Indirect Spend Optimization (ZBB) and product redesign work-stream, delivering over $100M of savings in one year.

• Program management lead for driving Baxter’s Transformation. Program consists of implementing zero-based budgeting, zero-based organization, creating a centralized global back office function, as well as driving process and portfolio simplification driving over $1B of savings. • Includes monthly progress readouts to the operating committee and preparing quarterly material for the Board of Directors.

• Global head of ~$300MM IV preparation and automation business while maintaining head of strategy for $2.3B global Integrated Pharmacy Solutions business. • IPA overachieved vs plan in both Revenue and Gross Margin by focusing efforts on target global markets, exiting non-strategic & lower potential markets, and price optimization. Additionally, streamlined portfolio by removing 40% of SKUs and optimizing price on remaining SKUs.• Reprioritized R&D pipeline to focus on key product lines & key geographies. • Led the closure of Baxter’s presence in Colorado. Activities included planning transition of R&D and commercial work to Deerfield as well as managing the overall communication plan including a plant closure.

• In charge of strategy for the $2.3 B global Integrated Pharmacy Solutions Franchise as well as direct responsibility for the ICNET (software services) and pharmacy consulting business. •Led global marketing plan development and roll out for IPS (integrated pharmacy solutions) across 5 regions (over 20 key countries) and development of long term strategy for the Board of Directors.•Developed divisional M&A strategy; worked with business leads within IPS as well as the corporate business development team. Resulted in approval of 2 deals that will add $100MM + over the LRP.

Direct line responsibility for Contracting, Sales, and Marketing for BioPharma Solutions, Baxter's contract manufacturing. Overall leader for business unit, including dotted line full cross functional responsibility.• In charge of sales, marketing, contracting, and strategy for BioPharma Solutions, the ~$500MM contract manufacturing division of Baxter Healthcare. Additionally responsible for setting and coordinating franchise goals across Manufacturing, R&D, Legal, Quality, and Regulatory.• Streamlined sales management by implementing a CRM system with 100% sales force compliance, as well as installed automatically generated scorecards highlighting key metrics to easily assess pipeline richness as well as what opportunities senior management should be focused on. • Changed the incentives structure to prioritize new contracts and margin over revenue dollars and renewals; this - along with the sales management system -resulted in an increase of contracts signed by 30% YOY.• Led negotiations on several key $10MM dollar+ contracts with large pharmaceutical clients.

Responsible for marketing for BioPharma Solutions, the Contract Manufacturing Arm of Baxter. Responsibilities included developing price bands, marketing material, competitive intelligence, and strategy.• Responsibilities include defining marketing mix, setting pricing, supporting contract negotiations, defining acquisition targets, implementing operating mechanisms, creating the strategic plan, and supporting the definition of the long range plan.• Re-defined marketing mix by implementing and acting upon ROI metrics; applying this analytical framework led to changing the spend from brick and mortar conference spend to higher value online advertising which resulted in an increase in qualified leads while reducing overall marketing spend.

US Region product marketing lead for Brevibloc Premixed Bag• Increased margin by $14M by increasing revenue from $38M to $46M and reduced costs by $6MM by optimizing salesforce structure and go to market strategy. • Led a team that redesigned the US Specialty Pharma Sales Force. Activities included developing sales response curves, segmenting the market, territory alignment, modeling financial impact, and getting buy in from key constituents. • Developed tactical marketing material including working with an agency to develop a website and a scientific presentation for a leading KOL. Routed material through ad-prom successfully.

Managed the Integration of Renal and Medical Delivery into the newly formed Medical Products division.• Managed integration of Renal ($2.4B) and Medical Delivery ($4.7B) businesses to form the Medical Products division to gain synergies in functions, commercial effectiveness, and R&D productivity.• Developed operating mechanisms and tracking system to ensure 15 + different integration workstreams with 100+ people achieved key milestones and synergies on time and in a coordinated fashion. • Reported integration progress to the CEO and Presidents of both BioScience and Medical Products.• Worked with President of Medical Products and Senior Leadership Team to develop high level organizational structure and physically realign different groups to drive work efficiencies.• Developed and executed a global, synchronized communication.

• Developed business case and detailed economic model for implementing TetraVitae’s technology in strategic markets. Synthesized learnings with CEO and VP into presentations given to strategic partners and venture capitalists. • Led chemical purification project which included partner selection, contract negotiation, project planning, and execution management. Chemical purification was a significant milestone for the corporation and enabled product acceptance testing by potential customers.

Organizational and Operational Transformation• Collaborated with clients to develop a plan to reduce non-value added complexity resulting in $50M of margin improvement for a large pharmaceutical company. Activities included managing brainstorming sessions, facilitating meetings regarding product feature costs/benefits between commercial and manufacturing, managing financial analysis, conducting customer research, and presenting results to a committee composed of the COO, VP of Sales, and VP of Operations.• Directed team of fifteen people to improve manufacturing efficiency for a division of a major CPG company, resulting in savings of $50M dollars. Achieved results by identifying and prioritizing opportunities for improvement, developing a plan to address opportunities and codify learnings, sharing learnings across the plant network, and implementing a tracking system.Strategy • Collaborated with executives at a hospital network to develop a strategy regarding how to most effectively serve their largest market, resulting in the closure of two unprofitable hospitals and replacing them with a new facility driving $40M in improved margin. Personally developed the revenue model via consumer research, physician interviews, and demographic analysis.• Worked with a team to develop a portfolio strategy for a $2B office supply company. Activities included developing a fact base (composed of items such as category economics, market share, and customer preference), ideating with management, interviewing customers, and assessing competitive threats. Business Due Diligence for Private Equity Firms• Conducted business due diligence on 7 target companies in the following industries: fashion, IT distribution, mobile storage, building supplies, mattresses, electrical fittings, and information management. Target companies ranged from $100M to $6.7B in yearly revenue.

Interned before full time